设为首页 加入收藏 登录旧版
个体化解剖匹配骨植入假体的上市前临床评价及上市后研究要求*
The pre-market clinical evaluation and requirement on post-market study of individualized anatomy-matching bone prosthesis
  
DOI:
中文关键词:  个体化解剖匹配  定制  骨植入  临床评价  上市后研究
英文关键词:Individualized anatomy-matching  Customization  Bone implant  Clinical evaluation  Post-market study
基金项目:
作者单位
郭晓磊 卢忠 刘斌  
摘要点击次数: 631
全文下载次数: 370
中文摘要:
      目的 探索个体化解剖匹配(广义定制)骨植入假体的上市前注册资料技术审评关注点,以区别于型号规格参数定型的骨植入物。同时,对“定制”概念进行细分梳理,探索与审评结论相适应的、对定制产品上市后研究的要求。方法 在专家咨询会及初步补充资料的基础上,审评员对申请注册的“个性化定制型颅颌面骨外科修复重建植入物”进行技术审评,并提出补充研究的要求;在与审评员的密切沟通下,生产企业研发者及临床试验研究者针对产品设计规范,补充进行了设计开发的临床确认工作。针对开放的、单组的、非随机的、自身对照病例系列研究的固有缺陷,补充相同病患群体接受传统重建接骨板治疗的回顾性研究数据,形成历史性的病例对照研究;基于对比结果的临床显著性,审评员评价产品上市风险,并与生产企业共同分析,细化了对产品上市后研究的要求。结果 有别于型号规格参数定型的骨植入物产品的注册产品标准,审评员促使企业形成定性的、具有设计边界的产品设计规范;基于上市前设计开发验证与确认所形成的先验信息,审评结论提出了进一步的临床和非临床两方面的上市后研究要求,包括产品设计参数与性能数据累积,及临床随访数据的汇总统计要求。这些内容与企业制定的上市后研究方案相互补。结论 有别于型号规格参数设计定型的骨科医疗器械,个体化解剖匹配骨植入假体的风险控制,必须整合上市前后两部分的临床研究信息,以对综合风险趋势做出判定。审评机构应促进个体化定制到批量化标准产品的转化,加速精准医疗产品的研发,助力国产医疗器械原创研发实现换道超车。
英文摘要:
      Objective To explore technical concerns during pre-market registration evaluation on individualized anatomy-matching bone prosthesis (IAMP, generalized customization), which are different from regular bone implants with committed parameters on types and specification. Also to subdivide the concept on customization, and to explore requirement on post-market study corresponding to conclusion of evaluation. Methods Based on expert panel consultation and primary supplement, CMDE reviewers conducted technical review and required additional research on characterized customized craniomaxillofacial reconstructive implant; based on close communication with CMDE reviewer, R&D group and clinical investigators supplemented clinical validation on design & development according to product design specification. Due to the inherent defect on opened, single group, non-randomized, self-controlled longitudinal case series, the investigators collected the retrospective study on equivalent patient population of reconstructive plates, to form historical case-control study; based on the clinical significance of above contrastive study, the reviewers assessed on-market risk, and cooperated with manufacture to form detailed post-market study requirement. Results Distinguished from registration product standard of regular committed medical devices, reviewer enhanced qualitative design specification with design boundary; based on priori information of pre-market D&D verification and validation, the reviewer concluded advanced requirement on post-market clinical/non-clinical study which complemented with the manufacture’s post market study plan, including accumulation of product design parameters and performance data, and statistical summary of clinical follow-up data. Conclusions Based on that the clinical validation is different from regular implants with committed parameters on types and specification, the risk control of IAMP should combine pre and post market clinical study data to integrate appraisal on risk tendency. So that the D&D circle from individual customization to batch-produced standardized product can be properly accelerated, and we hope the overtaking corners for original design and development of domestic medical device can be assisted.
查看全文  查看/发表评论  下载PDF阅读器
扫码关注
《生物骨科材料与临床研究》微信公众号